Ignite Creation Date:
2024-05-06 @ 12:42 PM
Last Modification Date:
2024-10-26 @ 1:03 PM
Study NCT ID:
NCT03829410
Status:
COMPLETED
Last Update Posted:
2024-03-01
First Post:
2019-02-01
Brief Title:
Onvansertib in Combination With FOLFIRI and Bevacizumab for Second Line Treatment of Metastatic Colorectal Cancer Patients With a Kras Mutation
Sponsor:
Cardiff Oncology
Organization:
Cardiff Oncology
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-05-06
Start Date Type:
ACTUAL
Primary Completion Date:
2024-01-29
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-01-29
Completion Date Type:
ACTUAL
First Submit Date:
2019-02-01
First Submit QC Date:
February 1 2019
Study First Post Date:
2019-02-04
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-02-29
Last Update Post Date:
2024-03-01
Last Update Post Date Type:
ACTUAL